![Gerald Carlson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gerald Carlson
Algemeen Directeur bij Phibro Animal Health (Belgium) SA
Profiel
Gerald K.
Carlson is currently the Chief Executive Officer at Phibro Animal Health (Belgium) SA. Previously, he worked as the Chief Operating Officer & Director at Phibro Animal Health Corp.
from 2014 to 2016.
He also worked as the Senior VP-Corporate Planning & Development at Ecolab, Inc. in 1998 and as the Commissioner-Trade & Development at State of Minnesota from 1999 to 2001.
Actieve functies van Gerald Carlson
Bedrijven | Functie | Begin |
---|---|---|
Phibro Animal Health (Belgium) SA
![]() Phibro Animal Health (Belgium) SA Agricultural Commodities/MillingProcess Industries Phibro Animal Health SA (Belgium) manufactures animal health and nutrition products. The company's plant utilizes fermentation processes to produce the ingredients semduramicin-crystalline and virginiamycin; and also manufactures Stafac formulations. The company was founded in 2000 and is headquartered in Wavre, Belgium | Algemeen Directeur | 08-06-2011 |
Eerdere bekende functies van Gerald Carlson
Bedrijven | Functie | Einde |
---|---|---|
State of Minnesota | Corporate Officer/Principal | 01-01-2001 |
ECOLAB INC. | Corporate Officer/Principal | 01-10-1998 |
PHIBRO ANIMAL HEALTH CORPORATION | Algemeen Directeur | 01-03-2014 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PHIBRO ANIMAL HEALTH CORPORATION | Health Technology |
ECOLAB INC. | Process Industries |
Bedrijven in privébezit | 2 |
---|---|
Phibro Animal Health (Belgium) SA
![]() Phibro Animal Health (Belgium) SA Agricultural Commodities/MillingProcess Industries Phibro Animal Health SA (Belgium) manufactures animal health and nutrition products. The company's plant utilizes fermentation processes to produce the ingredients semduramicin-crystalline and virginiamycin; and also manufactures Stafac formulations. The company was founded in 2000 and is headquartered in Wavre, Belgium | Process Industries |
State of Minnesota | Government |